sovaldi
Egyptian Ministry of Health refuted in a press statement issued Monday rumors circulated via social media that Sovaldi drug for Hepatitis C causes liver cancer.
“The first Egyptian-American alternative to Harvoni and Magicbuvir Plus for treating patients infected with the Hepatitis C virus (HCV) will be available soon
The prevalence rate of HCV reached 14.5 percent in 2008; a percentage that the state aims to curb by 2022.
An estimated 325 million people are living with hepatitis B or C and few are aware of their condition
Most Read